Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2025-12-24 @ 11:13 PM
NCT ID:
NCT00117169
Eligibility Criteria:
Inclusion Criteria:
* All outpatients admitted to the emergency ward for suspected pulmonary embolism, defined as acute onset of new or worsening shortness of breath or chest pain without another obvious etiology, will be included in the study, provided they meet all other criteria and they have signed an informed consent form.
Exclusion Criteria:
* PE suspicion raised more than 24 hours after admission to the hospital
* Absence of informed consent
* Life expectancy of less than 3 months
* Geographic inaccessibility for follow-up
* Pregnancy
* Patients anticoagulated for a disease other than venous thromboembolism (for instance, atrial fibrillation)
* Patients allergic to contrast medium
* Impaired renal function (creatinine clearance less than 30 ml/min, as calculated by the Cockroft formula)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00117169
Study Brief:
Protocol Section:
NCT00117169